{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:27:12Z","timestamp":1773779232052,"version":"3.50.1"},"reference-count":40,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Breathe"],"accepted":{"date-parts":[[2026,2,9]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    Pulmonary mycoses encompass a broad spectrum of pathogens, including filamentous moulds, dimorphic fungi and fungi with predominantly yeast-like growth forms. Susceptibility is driven by defects in T-helper (Th)1\/Th17 immunity, neutrophil dysfunction and barrier disruption. Clinical presentation varies widely, ranging from asymptomatic colonisation to rapidly progressive, life-threatening disease, depending on host immune status and pathogen type. Radiological findings, particularly on high-resolution computed tomography, often provide critical diagnostic clues but are rarely pathognomonic. Although histopathological evidence remains the gold standard, advancements in complementary diagnostics are increasingly being integrated into clinical workflows. Broad-range fungal markers such as (1\u21923)-\u03b2-\n                    <jats:sc>d<\/jats:sc>\n                    -glucan can guide diagnosis, while both culture- and nonculture-based tests are warranted for further pathogen identification, each offering unique advantages and constraints. Management emphasises prompt, guideline-concordant therapy. Emerging antifungal agents and host-directed immunotherapeutic approaches offer promise against resistant or refractory disease. This review synthesises current knowledge on species-specific epidemiology, clinical manifestations, radiological features, diagnostic methods and therapeutic options for pulmonary mycoses, highlighting practical considerations for clinicians managing these complex diseases.\n                  <\/jats:p>","DOI":"10.1183\/20734735.0165-2025","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:16:50Z","timestamp":1773767810000},"page":"250165","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pulmonary mycoses: a clinical perspective"],"prefix":"10.1183","volume":"22","author":[{"given":"Klara","family":"Verstappen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3230-0879","authenticated-orcid":false,"given":"C\u00e9dric","family":"Bosteels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7242-0747","authenticated-orcid":false,"given":"Eva","family":"Van Braeckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"2026031702300671000_22.1.250165.1","doi-asserted-by":"crossref","first-page":"101728","DOI":"10.1016\/j.smim.2023.101728","article-title":"Immunity to fungi in the lung","volume":"66","author":"Heung","year":"2023","journal-title":"Semin Immunol"},{"key":"2026031702300671000_22.1.250165.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00191-2"},{"key":"2026031702300671000_22.1.250165.3","doi-asserted-by":"publisher","DOI":"10.1038\/S41577-022-00826-W"},{"key":"2026031702300671000_22.1.250165.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.12.970"},{"key":"2026031702300671000_22.1.250165.5","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jaip.2019.11.031","article-title":"Dupilumab treatment for allergic bronchopulmonary aspergillosis: a case series","volume":"8","author":"Ramonell","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026031702300671000_22.1.250165.6","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1056\/NEJMoa2000024","article-title":"Disseminated coccidioidomycosis treated with interferon-\u03b3 and dupilumab","volume":"382","author":"Tsai","year":"2020","journal-title":"N Engl J Med"},{"key":"2026031702300671000_22.1.250165.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00692-8"},{"key":"2026031702300671000_22.1.250165.8","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026031702300671000_22.1.250165.9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000520111","article-title":"Candida pneumonia: an innocent bystander or a silent killer?","volume":"31","author":"Meena","year":"2022","journal-title":"Med Princ Pract"},{"key":"2026031702300671000_22.1.250165.10","unstructured":"Carroll KC , Pfaller MA , Landry ML , et al. Manual of Clinical Microbiology. 13th Edn. Washington, ASM Press (American Society for Microbiology)\/Wiley, 2023."},{"key":"2026031702300671000_22.1.250165.11","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/cid\/ciaa1786","article-title":"Defining galactomannan positivity in the updated EORTC\/MSGERC consensus definitions of invasive fungal diseases","volume":"72","author":"Mercier","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026031702300671000_22.1.250165.12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1777259"},{"key":"2026031702300671000_22.1.250165.13","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00027-06"},{"key":"2026031702300671000_22.1.250165.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-6646(08)60199-0"},{"key":"2026031702300671000_22.1.250165.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra032588"},{"key":"2026031702300671000_22.1.250165.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2009.10.010"},{"key":"2026031702300671000_22.1.250165.17","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S2213-2600(22)00259-4","article-title":"Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study","volume":"10","author":"Feys","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2026031702300671000_22.1.250165.18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00330-017-5007-5","article-title":"Pulmonary mucormycosis: serial morphologic changes on computed tomography correlate with clinical and pathologic findings","volume":"28","author":"Nam","year":"2018","journal-title":"Eur Radiol"},{"key":"2026031702300671000_22.1.250165.19","first-page":"528","article-title":"Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis","volume":"55","author":"Eigl","year":"2017","journal-title":"Med Mycol"},{"key":"2026031702300671000_22.1.250165.20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw326"},{"key":"2026031702300671000_22.1.250165.21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2026031702300671000_22.1.250165.22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0043-1776776","article-title":"Antifungal therapies for Aspergillus spp: present and future","volume":"45","author":"Eschenauer","year":"2024","journal-title":"Semin Respir Crit Care Med"},{"key":"2026031702300671000_22.1.250165.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00803-2024"},{"key":"2026031702300671000_22.1.250165.24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00583-2015"},{"key":"2026031702300671000_22.1.250165.25","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01821-18"},{"key":"2026031702300671000_22.1.250165.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03456.x"},{"key":"2026031702300671000_22.1.250165.27","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00061-2024"},{"key":"2026031702300671000_22.1.250165.28","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.3.556-569.2005"},{"key":"2026031702300671000_22.1.250165.29","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30312-3"},{"key":"2026031702300671000_22.1.250165.30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jinf.2020.05.051","article-title":"Evaluation of MucorGenius\u00ae mucorales PCR assay for the diagnosis of pulmonary mucormycosis","volume":"81","author":"Guegan","year":"2020","journal-title":"J Infect"},{"key":"2026031702300671000_22.1.250165.31","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00039-07"},{"key":"2026031702300671000_22.1.250165.32","doi-asserted-by":"publisher","DOI":"10.3201\/eid2203.151117"},{"key":"2026031702300671000_22.1.250165.33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2008-740ST"},{"key":"2026031702300671000_22.1.250165.34","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/cid\/ciad619","article-title":"Clinical testing guidance for coccidioidomycosis, histoplasmosis, and blastomycosis in patients with community-acquired pneumonia for primary and urgent care providers","volume":"78","author":"Smith","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026031702300671000_22.1.250165.35","doi-asserted-by":"publisher","DOI":"10.1086\/521259"},{"key":"2026031702300671000_22.1.250165.36","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-009-1482-8"},{"key":"2026031702300671000_22.1.250165.37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s11046-021-00575-9","article-title":"Update on pulmonary cryptococcosis","volume":"186","author":"Yamamura","year":"2021","journal-title":"Mycopathologia"},{"key":"2026031702300671000_22.1.250165.38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/jof7040260","article-title":"Associations between Cryptococcus genotypes, phenotypes, and clinical parameters of human disease: a review","volume":"7","author":"Montoya","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2026031702300671000_22.1.250165.39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s12890-022-02175-9","article-title":"Comparison of the clinical manifestations and chest CT findings of pulmonary cryptococcosis in immunocompetent and immunocompromised patients: a systematic review and meta-analysis","volume":"22","author":"Xiong","year":"2022","journal-title":"BMC Pulm Med"},{"key":"2026031702300671000_22.1.250165.40","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw167"}],"container-title":["Breathe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/20734735.0165-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:16:54Z","timestamp":1773767814000},"score":1,"resource":{"primary":{"URL":"http:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/20734735.0165-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,17]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1183\/20734735.0165-2025"],"URL":"https:\/\/doi.org\/10.1183\/20734735.0165-2025","relation":{},"ISSN":["1810-6838","2073-4735"],"issn-type":[{"value":"1810-6838","type":"print"},{"value":"2073-4735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}